Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication
management and supply chain solutions for health systems, today
announced that St. Luke’s University Health Network, a non-profit,
regional, fully integrated, nationally recognized network providing
services at 10 hospitals and more than 315 sites in eastern Pennsylvania
and western New Jersey, has awarded the Company a five-year sole source
contract to provide automation solutions that will support medication
management across the health system.
St. Luke’s will leverage Omnicell’s industry-leading medication
management platform to enhance control, efficiency and safety of its
medication management processes, including advanced technologies to
automate dispensing and storage in Central Pharmacy, sterile compounding
automation, and medication
dispensing cabinets in patient care areas. Automating manual,
error-prone workflows will help to streamline medication management and
free up staff for more clinically focused activities.
According to the American Pharmacist Association (APhA), positive
interaction with hospital pharmacists can significantly impact patient
satisfaction survey scores.1 Pharmacists can play a key role
in positively affecting patient outcomes with various clinical programs
such as medication reconciliation, discharge management, and opioid
stewardship.
“Automation offers many benefits, including increased safety,
efficiency, and cost savings,” said Patrick Ferguson, RPh, MBA, network
director of pharmacy services at St. Luke’s University Health Network.
“Automation also shifts the focus of our pharmacy staff from logistical
tasks to a more active role in patient care, improving job satisfaction
and supporting our commitment to patient-centered care.”
St. Luke’s was recently a development partner for the Omnicell® XR2
Automated Central Pharmacy System, a robotic technology solution
designed to automate critical workflows in the Central Pharmacy. With
high capacity and formulary coverage, significant efficiency
improvements, and more accurate management of inventory levels, XR2 is a
key technological step in Omnicell’s vision to develop a fully automated
medication management infrastructure, known as Autonomous Pharmacy.
“St. Luke’s understands the role automation plays in elevating pharmacy
practice,” said Scott Seidelmann, executive vice president and chief
commercial officer at Omnicell. “The extension of our partnership
through this agreement will help them to enhance medication management
across the continuum of care, while improving efficiency and job
satisfaction for their staff.”
About St. Luke’s University Health Network
St. Luke’s University Health Network (SLUHN) is a non-profit, regional,
fully integrated, nationally recognized network providing services at
ten hospitals and more than 315 sites in Lehigh, Northampton, Carbon,
Schuylkill, Bucks, Montgomery, Berks and Monroe counties in Pennsylvania
and Warren and Hunterdon counties in New Jersey.
About Omnicell
Since 1992, Omnicell has been inspired to create safer and more
efficient ways to manage medications across all care settings. As a
leading provider of solutions across the continuum of care, we offer a
path to fully automated medication management infrastructure, powered by
a cloud data platform that supports improved patient care, fewer errors,
enhanced safety, and new opportunities for growth.
Our vision for the Autonomous Pharmacy integrates a comprehensive set of
solutions powered by the Omnicell Cloud Data Platform across three key
areas: Automation – solutions designed to digitize and streamline
workflows; Intelligence – actionable insights to better understand
medication usage and improve pharmacy supply chain management; and Work
– expert services that serve as an extension of pharmacy operations to
support improved efficiency, regulatory compliance, and patient outcomes.
Over 5,500 facilities worldwide use Omnicell automation and analytics
solutions to increase operational efficiency, reduce medication errors,
deliver actionable intelligence, and improve patient safety. And more
than 40,000 institutional and retail pharmacies across North America and
the United Kingdom leverage Omnicell’s innovative medication adherence
solutions to improve patient engagement and adherence to prescriptions,
helping to reduce costly hospital readmissions.
To learn more about Omnicell and our Autonomous Pharmacy vision, please
visit omnicell.com.
OMCL-G
Editor’s Notes:
-
All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by BusinessWire and are
immediately thereafter posted on the company’s external website, omnicell.com. -
Omnicell and the Omnicell logo design are registered trademarks of
Omnicell, Inc. -
All other brand or product names may be trademarks or registered
trademarks of their respective companies.
1 Erickson, A. K. (2013, October 11). “Survey says:
Pharmacists affect patient satisfaction.” Retrieved January 08, 2018
from https://www.pharmacist.com/survey-says-pharmacists-affect-patient-satisfaction
View source version on businesswire.com: https://www.businesswire.com/news/home/20190508005172/en/